Observational analysis links fish oil supplements to genetic variants affecting fatty acid traits in UK Biobank
This publication is an observational analysis utilizing a subset of the UK Biobank comprising 200,478 participants. The study investigated the relationship between fish oil supplements (FOS) and genetic variants (vQTLs) regarding 14 plasma polyunsaturated fatty acid (PUFA) and monounsaturated fatty acid (MUFA) phenotypes. No specific follow-up duration or setting details were reported in the source material.
The primary findings highlighted the identification of 172 vQTL-trait pairs across all 14 traits at genome-wide significance, defined as p < 5.0 x 10-8. These results involved 46 non-overlapping loci with an average of 12 vQTLs per trait. Additionally, six significant interaction signals were observed in DHA, DHA%, Omega-3, Omega-3%, LA, and the Omega-6/Omega-3 ratio around the FADS1/2, ZPR1, and SUGP1/TM6SF2 genes.
The authors explicitly note that this is an observational study, meaning associations do not imply causation. No adverse events, tolerability data, or discontinuations were reported. Consequently, the practice relevance remains uncertain, and clinicians should interpret these genetic and supplement associations with caution rather than as evidence for therapeutic efficacy.